Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.8 |
| Revenue growth | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 23.7 |
| Gross profit | 0.0 | 0.0 | 0.0 | -22.9 |
| Gross margin | | | | -2981.5% |
| Research and development | 171.5 | 64.3 | 21.1 | |
| General and administrative | 165.1 | 176.7 | 3.5 | 0.1 |
| EBITA | -347.4 | -358.3 | -24.6 | -23.7 |
| EBITA margin | | | | -3081.5% |
| Amortization of intangibles | | | 0.0 | |
| EBIT | -347.4 | -358.3 | -24.6 | -23.7 |
| EBIT margin | | | | -3081.5% |
| Pre-tax income | -317.3 | -347.8 | -24.8 | -0.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -317.3 | -347.8 | -24.8 | -0.9 |
| Net margin | | | | -122.8% |
| |
| Diluted EPS | ($1.32) | ($3.14) | ($0.49) | |
| Shares outstanding (diluted) | 240.5 | 110.8 | 50.2 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|